Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

Bilger, G; Toffart, AC; Darrason, M; Duruisseaux, M; Ulmer, L; Wang, P; Leprieur, EG; Girard, N; Massiani, MA; Bore, P; Descourt, R; Pinsolle, J; Valery, S; Monnet, I; Swalduz, A; Tissot, C; Fournel, P; Baranzelli, A; Cortot, AB; Decroisette, C

Bilger, G (通讯作者)，Univ Grenoble, Ctr Hosp, F-38700 Grenoble, France.;Bilger, G (通讯作者)，Grenoble Univ Hosp, Oncol, F-38700 Grenoble, France.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022; 14 ():

Abstract

Introduction: Compared with docetaxel, the phase-III trial, ULTIMATE, showed a signi?cant improvement of progression-free survival (PFS) with paclitax......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索